MAI Capital Management’s Zimmer Biomet ZBH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$209K Sell
2,425
-125
-5% -$11K ﹤0.01% 1791
2026
Q1
$231K Sell
2,550
-100
-4% -$9.18K ﹤0.01% 1392
2025
Q4
$238K Sell
2,650
-1,163
-31% -$110K ﹤0.01% 1249
2025
Q3
$376K Buy
3,813
+757
+25% +$75K ﹤0.01% 1017
2025
Q2
$279K Buy
3,056
+498
+19% +$48.2K ﹤0.01% 1034
2025
Q1
$289K Sell
2,558
-16
-0.6% -$1.71K ﹤0.01% 991
2024
Q4
$272K Sell
2,574
-129
-5% -$13.8K ﹤0.01% 1024
2024
Q3
$292K Sell
2,703
-1,497
-36% -$163K ﹤0.01% 892
2024
Q2
$456K Sell
4,200
-264
-6% -$31.1K ﹤0.01% 845
2024
Q1
$589K Buy
4,464
+263
+6% +$32.9K 0.01% 737
2023
Q4
$511K Buy
4,201
+1,376
+49% +$154K 0.01% 699
2023
Q3
$317K Sell
2,825
-395
-12% -$50.2K ﹤0.01% 801
2023
Q2
$469K Buy
3,220
+193
+6% +$26.2K 0.01% 667
2023
Q1
$391K Sell
3,027
-164
-5% -$20.6K 0.01% 718
2022
Q4
$407K Sell
3,191
-131
-4% -$15.2K 0.01% 669
2022
Q3
$347K Sell
3,322
-897
-21% -$98.4K 0.01% 664
2022
Q2
$443K Buy
4,219
+36
+0.9% +$4.27K 0.01% 574
2022
Q1
$535K Sell
4,183
-114
-3% -$13.7K 0.01% 542
2021
Q4
$530K Buy
4,297
+152
+4% +$19.9K 0.01% 561
2021
Q3
$589K Buy
4,145
+267
+7% +$39.3K 0.01% 471
2021
Q2
$605K Buy
3,878
+282
+8% +$45.7K 0.01% 461
2021
Q1
$559K Buy
3,596
+195
+6% +$30.2K 0.01% 456
2020
Q4
$509K Buy
3,401
+417
+14% +$58.9K 0.01% 449
2020
Q3
$394K Sell
2,984
-331
-10% -$43.2K 0.01% 433
2020
Q2
$384K Sell
3,315
-272
-8% -$31.3K 0.01% 429
2020
Q1
$352K Buy
+3,587
New +$470K 0.01% 420

Other funds holding ZBH

MAI Capital Management's ZBH Position: Q2 2026 in Review

MAI Capital Management reduced its Zimmer Biomet (ZBH) stake by 4.9% in Q2 2026, selling an estimated $11K and leaving 2,425 shares worth $209K. The position accounts for ﹤0.01% of the portfolio, ranked #1791.

MAI Capital Management first reported a position in ZBH in Q1 2020 and has held it in 26 quarters since. The position peaked at $605K in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.

  • MAI Capital Management held 2,425 shares of Zimmer Biomet worth $209K as of Q2 2026.
  • MAI Capital Management sold 125 Zimmer Biomet shares in Q2 2026, an estimated $11K.
  • Zimmer Biomet made up ﹤0.01% of MAI Capital Management's portfolio in Q2 2026, its #1791 holding.
  • MAI Capital Management first reported a position in Zimmer Biomet in Q1 2020 and has held it in 26 quarters since.
  • MAI Capital Management's Zimmer Biomet position peaked at $605K in Q2 2021.
  • 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.

Based on MAI Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.